Integrum AB Class B AI Stock Analysis
Integrum AB Class B (6Y1) AI Stock Analysis
Integrum AB Class B
(Frankfurt:6Y1)
No summary available
Integrum AB Class B (6Y1) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 21.75M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -5.7
- Beta (1Y)
- 0.73
- Revenue Growth
- 4.66%
- EPS Growth
- 1.71%
- Country
- Germany
- Employees
- 33
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Devices
Integrum AB Class B Business Overview & Revenue Model
Company Description
Integrum AB (publ) focuses on the research, development, and global sale of advanced bone-anchored prosthetic solutions. A core offering is the Osseointegrated Prostheses for the Rehabilitation of Amputees (OPRA) implant system. This innovative bone-...
Integrum AB Class B Peers Comparison
Overall Rating
SE:SECT.B74Outperform
SE:GETI.B67Neutral
SE:SEZI55Neutral
SE:BACTI.B53Neutral
SE:OSSD45Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 74Outperform | SEK 63.88B | 100.12 | 30.26% | 0.70% | 13.94% | 5.70% | |
| 67Neutral | SEK 76.89B | 27.17 | 9.13% | 1.68% | -3.90% | 37.73% | |
| 55Neutral | SEK 532.17M | -5.46 | -35.44% | ― | 18.56% | 28.11% | |
| 53Neutral | SEK 523.91M | 83.06 | 1.93% | ― | -0.51% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 45Neutral | SEK 386.08M | -7.72 | ― | ― | -11.89% | -11.85% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:6Y1 | Integrum AB Class B | 0.69 | -0.06 | -7.87% | |
| SE:GETI.B | Getinge AB (UK) | 282.30 | 79.58 | 39.25% | |
| SE:SEZI | Senzime AB | 3.38 | -1.57 | -31.62% | |
| SE:BACTI.B | Bactiguard Holding AB | 14.95 | -3.80 | -20.27% | |
| SE:SECT.B | Sectra AB Class B | 327.40 | 50.21 | 18.11% | |
| SE:OSSD | OssDsign AB | 3.49 | -7.25 | -67.50% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
